Chiral switch: Pure enantiomers of drugs instead of racemic mixtures;Chirální záměna - "Chiral switch": Čisté enantiomery léčiv místo r racemických směsí

Ceska a Slovenska Farmacie

Volumn 53, Issue 6, 2004, Pages 285-293

  Valentová, Jindra ^a,c   Hutt, A J ^b  

^a Faculty of Natural Sciences   (Slovakia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NONE   (Slovakia)

Author keywords

Chiral drugs; Economic aspects; Enantiomers; Racemates

Indexed keywords

AMLODIPINE; CHIRAL SWITCH DRUG; CISAPRIDE; CISATRACURIUM; DEXFENFLURAMINE; DEXIBUPROFEN; DEXKETAMINE; DEXKETOPROFEN; DILEVALOL; DOXAZOSIN; DRUG; ESCITALOPRAM; ESOMEPRAZOLE; ESZOPICLONE; FLUOXETINE; FLURBIPROFEN; FORMOTEROL; LANSOPRAZOLE; LEVALBUTEROL; LEVOBUPIVACAINE; LEVOCETIRIZINE; LEVOFLOXACIN; METHYLPHENIDATE; NORCISAPRIDE; OXYBUTYNIN; PANTOPRAZOLE; SIBUTRAMINE; SOTALOL; UNCLASSIFIED DRUG;

CHIRALITY; DRUG ANALYSIS; DRUG EFFICACY; DRUG RESEARCH; DRUG SYNTHESIS; ECONOMIC ASPECT; ENANTIOMER; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; RACEMIC MIXTURE; REGULATORY MECHANISM; REVIEW; ARTICLE; CHEMISTRY; STEREOISOMERISM;

CHEMISTRY, PHARMACEUTICAL; STEREOISOMERISM;

EID: 8744314934     PISSN: 12107816     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Collins, A. N., Sheldrake, G. N., Crosby, J. (eds.): Chirality in Industry. New York, Wiley, 1992.
2. Collins, A. N., Sheldrake, G. N., Crosby, J. (eds.): Chirality in Industry II. New York, Wiley, 1997.
3. Krstulovic, A. M. (ed.): Chiral Separations by HPLC. Chichester, Ellis Horwood, 1989.
4. nd edition. New York, Marcel Deker, 1993.
5. Subramanian, G. (ed.): A Practical Approach to Chiral Separations by Liquid Chromatography. Weinheim, VCH, 1994.
6. Chankvetadze, B.: Capillary Electrophoresis in Chiral Analysis. Chichester, Wiley, 1997.
7. Aboul-Enein, H. Y., Wainer, I. W. (eds.): The Impact of Stereochemistry on Drug Development and Use. New York, Wiley, 1997.
8. Subramanian, G. (ed.): Chiral Separation Techniques. A Practical Approach. Weinheim, Wiley-VCH, 2001.
9. Challener, C. A. (ed.): Chiral Drugs. Aldershof, Ashgate, 2001.
10. Ariëns, E. J., Soudijn, W., Timmermans, P. B. H. W. H. (eds.): Stereochemistry and Biological Activity of Drugs. Oxford, Blackwell, 1993.
11. Smith, D. F. (eds.): Handbook of Stereoisomers: Therapeutic Drugs. Boca Raton, CRC Press, 1989.
12. Crossley, R: Chirality and the Biological Activity of Drugs. Boca Raton, CRC Press, 1995.
13. Eichelbaum, M., Gross, A. S.: In: Advances in Drug Research volume 23 (Testa, B., Meyer, U. A., ed.), London, Academic Press, 1996, s. 1.
14. Hutt, A. J., Tan, S. C.: Drugs, 1996; 52 (Suppl. 5), 1.
15. rd edition (Smith, H. J., ed.) Reading, Harwood Academic, 1998, s. 97.
16. Slováková, A., Hutt, A. J.: Čes. a Slov. Farm., 1999; 48, 107.
17. De Camp, W. H.: Chirality, 1989; 1, 2.
18. Cayen, M. N.: Chirality, 1991; 3, 94.
19. Nation, R. L.: Clin Pharmacokinet., 1994; 27, 249.
20. Rauws, A. G., Groen, K.: Chirality, 1994; 6, 72.
21. Caldwell, J.: Chirality, 1989; 1, 249.
22. Hutt, A. J.: Chirality, 1991; 3, 161.
23. Gross, M., Cartwright, A., Campbell, B. et al.: Drug Info. J., 1993; 193, 453.
24. FDA: Chirality, 1992; 4, 338.
25. nd edition, (Subramanian, G., ed.). Weinheim, Wiley-VCH, 2001, s. 319.
26. Shindo, H., Caldwell, J.: Chirality, 1995; 7, 349.
27. Tucker, G.: Lancet, 2000; 355, 1085.
28. Walshe, J. M.: Am. J. Med., 1956; 21, 487.
29. Williams, K. M.: Pharmacol. Ter., 1990; 46, 273.
30. Glatt, H., Oesch, F.: Biochem. Pharmacol., 1985; 34, 3725.
31. Tu, J. B., Blackwell, R. Q., Lee, P. F.: J. Am. Med. Ass., 1963; 185, 83.
32. Walshe, J. M.: Lancet, 1992; 339, 254.
33. Cotzias, G. C., Van Woert, M. H., Schiffer, L. M.: New Engl. J. Med., 1967; 276, 374.
34. Cotzias, G. C., Papavasiliou, P. S., Gellene, R.: New Engl. J. Med., 1969; 280, 337.
35. Dewes, P., Thijssen, I., Mengel, A.: Poster II - 45 presented at the 41st Annual NCDEU Meeting. Phoenix, USA 2001.
36. Summary of Product Characteristics: Cipralex (Escitalopram), Lundbeck 2002.
37. Smith, E. R., Wright, S. E., Aberg, G. et al.: Arzneim.-Forsch., 1998; 48, 1012.
38. Jones, S. E., Shuba, L. M., Zhabyeyev, P. et al.: Br. J. Pharmacol., 2000; 131, 245.
39. Steiner, T. J., Ahmed, F., Findley, L. J. et al.: Cephalagia, 1998; 18, 283.
40. Glick, S. D., Haskew, R. E., Maisonneuve, I. M. et al.: Eur. Pharmacol., 2000; 397, 93.
41. Agranat, I., Caner, H., Caldwell, J.: Drug Discovery, 2002; 1, 753.
42. Keegan, P., Loughmam, B. E.: Urology, 2001; 57, 216.
43. Wechter, W. J., Kantoci, D., Murray, E. D. et al.: Cancer Res., 1997; 57, 4316.
44. Wechter, W. J., Leipold, D. D., Murray, E. D. et al.: Cancer Res. 2000; 60, 2203.
45. In't Veld, B. A., Ruitenberg, A., Hofman, A. et al.: New Engl. J. Med. 2001; 345, 1515.
46. Weggen, S., Eriksen, J. L., Das, P. et al.: Nature, 2001; 414, 212.
47. Morihara, T., Chu, T., Ubeda, O. et al.: J. Neurochem., 2002; 83, 1009.
48. Mahmud, T., Somasundaram, S., Sigthorsson, G. et al.: Gut, 1998; 43, 775.
49. Jerussi, T. P., Caubet, J. F., McCray, J. E., Handley, D. A.: J. Clin. Pharmacol., 1998; 38, 19.
50. Anonymous: Scrip Number, 1990; 1540, 24.
51. Shah, R. R., Midgley, J. M., Branch, S. K.: Adverse Drug React. Toxicol. Rev., 1998; 17, 145.
52. Advani, S. V., Singh, B. N.: Drugs, 1995; 49, 664.
53. Kato, R., Ikeda, N., Yabek, S. et al.: J. Am. Coll. Cardiol., 1986; 7, 116.
54. Waldo, A. L., Camm, A. J., De Ruyter, H. et al.: Lancet, 1996; 348, 7.
55. - -: Chem. Br., 2000; 36, II.
56. Thayer, A.: Chem. Eng. News, 2000; 30, 8.
57. Connolly, M. H., Cary, J. L., McGoon, M. D.: New Engl. J. Med., 1997; 337, 581.
58. - -: Currents problems in Pharmacovigilance, 1997; 23, 13.
59. Maier, N. M., Franco, P., Lindner, W.: J. Chromatogr. A, 2001; 906, 3.
60. Léger, B.: Drug Plus International, 2002; 1, 4.
61. Anonymous: Nature 418, 353 (2002).
62. Rouhi, A. M.: Chem. Eng. News, 2002; 80, 43.
63. Molony, J. L.: Drug discovery: design and serendipity. In: Principles and Practice of Pharmaceutical Medicine (Fletcher, A. J., Edwards, L. D., Fox, A. W., Stonier, P. eds.), Chichester, Wiley, 2002, s. 31.
64. Kromer, W.: Scand. J. Gastroenterol., 2001; 36 (Suppl. 243), 3.
65. Anderson, T., Hassan-Alin, M., Hasselgren, G. et al.: Clin. Pharmacokin., 2001; 40, 411.
66. - -: Scrip Number, 1990; 1543, 19.
67. Atarashi, S., Yokohama, S., Yamazaki, K. et al.: Chem. Pharm. Bull., 1987; 35, 1896.
68. Hayakawa, I., Atarashi, S., Yokohama, S. et al.: Antimicrob. Agents Chemother., 1986; 29, 163.
69. Imamura, M., Shibamura, S., Hayakawa, I., Osada, Y.: Antimicrob. Agents Chemother., 1987; 31, 325.
70. Davis, R., Bryson, H. M.: Drugs, 1994; 47, 677.
71. Hutt, A. J., O'Grady, J.: J. Antimicrob. Chemother., 1996; 37, 7.
72. Adams, S. S., Bresloff, P., Mason, C. G.: J. Pharm. Pharmacol., 1976; 28, 256.
73. Caldwell, J., Hutt, A. J., Fournel-Gigleux, S.: Biochem. Pharmacol., 1988; 37, 105.
74. Rahlfs, V. W.: J. Clin. Pharmacol., 1996; 36, 33.
75. Stock, K. P., Geisslinger, G., Loew, D. et al.: Rheumatol. Int., 1991; 11, 199.
76. Mauleón, D., Artigas, R., Garcia, M. L., Carganico, G.: Drugs, 1996; 52 (Suppl. 5), 24.
77. Nau, C., Vogel, W., Hempelmann, G., Bräu, M. R.: Anesthesiology, 1999; 91, 786.
78. Valenzuela, C., Delpón, E., Tamkun, M. M. et al.: Biophys. J., 1995; 69, 418.
79. Graf, B. M., Martin, E., Bosnjak, Z. J., Stowe, D. F.: Anesthesiology, 1997; 86, 410.
80. Bardsley, H., Gristwood, R., Baker, H. et al.: Br. J. Clin. Pharmacol., 1998; 46, 245.
81. Burke, D., Bannister, J.: Curr. Anaest. Crit. Care, 1999; 10, 262.
82. Foster, R. H., Markham, A.: Drugs, 2000; 59, 551.
83. Marietta, M. P., Way, W. L., Castagnoli, N., Trevor, A. J.: J. Pharmacol. Exp. Ther., 1977; 202, 157.
84. White, P. F., Ham, J., Way, W. L., Trevor, A. J.: Anesthesiol., 1980; 52, 231.
85. Kohrs, R., Durieux, M. E.: Anesth. Analg., 1998; 87, 1186.
86. Lind, T., Rydberg, L., Kylebäck, A. et al.: Aliment Pharmacol. Ther., 2000; 14, 861.
87. Spencer, C. M., Faulds, D.: Drugs, 2000; 60, 321.
88. Scott, L. J., Dunn, C. J., Mallarkey, G., Sharpe, M.: Drugs, 2002; 62, 1091.
89. Stenlake, J. B., Waigh, R. D., Dewar, G. H. et al.: Eur. J. Med. Chem., 1984; 19, 441.
90. Sun Wai, W. Y. S., Flynn, P. J.: Anaesth. Pharmacol. Rev., 1995; 3, 218.
91. Bryson, H. M., Faulds, D.: Drugs, 1997; 53, 848.
92. Page, C. P., Morley, J.: J. Allergy Clin. Immunol., 1999; 104, 31.
93. Nelson, H. S.: J. Allergy Clin. Immunol., 1999; 104, 77.
94. Hyttel, J., Břgesř, K. P., Perregaard, J., Sánchez, C.: J. Neural Trans., 1992; 88, 157.
95. Burke, W. J., Gergel, I., Bose, A.: J. Clin. Psychiatry, 2002; 63, 331.
96. Montgomery, S. A., Loft, H., Sánchez, C. et al.: Pharmacol. Toxicol., 2001; 88, 282.
97. Devalia, J. L., De Vos, C., Hanotte, F., Baltes, E.: Allergy, 2001; 56, 50.
98. Wang, D. Y., Hanotte, F., De Vos, C., Clement, P.: Allergy, 2001; 56, 339.
99. Patrick, K. S., Caldwell, R. W., Ferris, R. M., Breese, G. R.: J. Pharmacol. Exp. Ther., 1987; 241, 152.
100. Srinivas, N. R., Hubbard, J. W., Korchinski, E. D., Midha, K. K.: Pharm. Res., 1993; 10, 14.
101. - -: Scrip Number, 2001; 2698, 20.
102. Chlud, K.: J. Clin. Pharmacol., 1995; 35, 938.
103. Agranat, I. Caner, H.: Drug Discovery Today, 1999; 4, 313.
104. Strong, M.: Food Drug Law J., 1999; 54, 463.
105. Carlson, J. N., Haskew, R., Wacker, J. et al.: Eur. J. Pharmacol., 2001; 415, 181.
106. Hong, Y., Bakale, R. P., Fang, Q. K. et al.: Tetrahedron Asymmetry, 2000; 11, 4623.
107. Äbelö, A., Andersson, T. B., Bredberg, U. et al.: Drug Metab. Dispos., 2000; 28, 58.
108. Gillard, M., Van der Perren, C., Moguilevsky, N. et al.: Mol. Pharmacol., 2002; 61, 391.
109. Baltes, E., Coupez, R., Giezek, H. et al.: Fundam. Clin. Pharmacol., 2001; 15, 269.
110. Tillement, J.-P., Testa, B., Brée F.: Biochem. Pharmacol., 2003; 66, 1123.
111. Krystal, A. D., Walsh, J. K., Laska, E.: Sleep, 2003; 26, 793.
112. Burges, R. A., Gardiner, D. G., Gwilt, M. et al.: J. Cardiovasc. Pharmacol., 1987; 9, 110.
113. Zhang, X.-P., Loke, K. E., Mital, S. et al.: J. Cardiovasc. Pharmacol., 2002; 39, 208.
114. Laufen, H., Leitold, M.: Chirality, 1994; 6, 531.
115. Pathak, L., Hiremath, M. S., Kerkar, P. G. et al.: J. Assoc. Physicians India, 2004; 52, 197.
116. Adik-Pathak, L.: J. Assoc. Physicians India, 2004; 52, 187.